120 related articles for article (PubMed ID: 20046078)
41. Optimized quantification of lymphocyte subsets by use of CD7 and CD33.
Hauser A; Schrattbauer K; Najdanovic D; Schlossnickel R; Koch A; Hejtman M; Krugluger W
Cytometry A; 2013 Mar; 83(3):316-23. PubMed ID: 23315982
[TBL] [Abstract][Full Text] [Related]
42. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
43. Phenotypic quantitative features of patients with acute myeloid leukemia.
Pereira FG; Metze K; Costa FP; Lima CS; Lorand-Metze I
Neoplasma; 2006; 53(2):155-60. PubMed ID: 16575472
[TBL] [Abstract][Full Text] [Related]
44. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
[TBL] [Abstract][Full Text] [Related]
45. Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia.
Hoffmann MH; Klausen TW; Boegsted M; Larsen SF; Schmitz A; Leinoe EB; Schmiegelow K; Hasle H; Bergmann OJ; Sorensen S; Nyegaard M; Dybkaer K; Johnsen HE
Cytometry B Clin Cytom; 2012 May; 82(3):123-31. PubMed ID: 22328535
[TBL] [Abstract][Full Text] [Related]
46. CD3 gamma, CD3 delta, and CD3 zeta mRNA in adult human marrow hematopoietic progenitors correlates with surface CD2 and CD7 expression.
Long H; Gaffney P; Mortari F; Miller JS
Exp Hematol; 1996 Oct; 24(12):1402-8. PubMed ID: 8913286
[TBL] [Abstract][Full Text] [Related]
47. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
[TBL] [Abstract][Full Text] [Related]
48. [Aggressive natural killer cell leukemia: study of a case occurred in Africa and literature review].
Benmoussa A; Khalil K; Boufarissi F; Tazi I
Pan Afr Med J; 2018; 31():28. PubMed ID: 30918555
[TBL] [Abstract][Full Text] [Related]
49. Shifts in expression of immunological cell markers in relapsed acute leukemia.
Tomová A; Babusíková O
Neoplasma; 2001; 48(3):164-8. PubMed ID: 11583283
[TBL] [Abstract][Full Text] [Related]
50. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
51. Chronic lymphoproliferative disorder of NK-cells: A single-institution review with emphasis on relative utility of multimodality diagnostic tools.
Kurt H; Jorgensen JL; Amin HM; Patel KP; Wang SA; Lin P; Kanagal-Shamanna R; Loghavi S; Thakral B; Khogeer HA; Jabbour EJ; Li S; Yin CC; Medeiros LJ; Khoury JD
Eur J Haematol; 2018 May; 100(5):444-454. PubMed ID: 29385279
[TBL] [Abstract][Full Text] [Related]
52. CD56-Negative Aggressive NK Cell Leukemia Relapsing as Multiple Cranial Nerve Palsies: Case Report and Literature Review.
Guerreiro M; Príncipe F; Teles MJ; Fonseca S; Santos AH; Fonseca E; Gomes P; Marques C; Lima M
Case Rep Hematol; 2017; 2017():3724017. PubMed ID: 29163992
[TBL] [Abstract][Full Text] [Related]
53. Rapidly fatal leukemia comprising pleomorphic large granular lymphocytes: a report of 2 cases.
Win KT; Hsieh YC; Yang CC; Chang ST; Su YZ; Tien HF; Chuang SS
Anal Quant Cytopathol Histpathol; 2013 Aug; 35(4):232-6. PubMed ID: 24341127
[TBL] [Abstract][Full Text] [Related]
54. Variable manifestation in natural killer cell leukaemia.
Kuroda J; Kimura S; Kobayashi Y; Jyoko N; Kamitsuji Y; Murotani Y; Fukuda W; Akaogi T; Hayashi H; Yoshikawa T; Maekawa T
Clin Lab Haematol; 2003 Aug; 25(4):239-45. PubMed ID: 12890163
[TBL] [Abstract][Full Text] [Related]
55. Clinical features and prognosis of chronic natural killer cell lymphoproliferative disorders.
Liu DL; Wang YJ; Qian SY; Ma SS; Ding MJ; Dong M; Zhang JM; Zhang MZ; Chen QJ; Zhang XD
Hematology; 2024 Dec; 29(1):2307817. PubMed ID: 38319083
[TBL] [Abstract][Full Text] [Related]
56. The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis.
Kameda K; Yanagiya R; Miyatake Y; Carreras J; Higuchi H; Murayama H; Ishida T; Ito A; Iida S; Fukuhara N; Harigae H; Fujioka Y; Takahashi N; Wada H; Ishida F; Nakazawa H; Ishihara R; Murakami Y; Tagawa H; Matsuura T; Nakagawa S; Iwabuchi S; Hashimoto S; Imadome KI; Nakamura N; Ishizawa K; Kanda Y; Ando K; Kotani A
Blood; 2023 Jul; 142(4):352-364. PubMed ID: 37146246
[TBL] [Abstract][Full Text] [Related]
57. Comprehensive molecular genetic studies of Epstein-Barr virus-negative aggressive Natural killer-cell leukemia/lymphoma.
Gao J; Zhang Y; Yaseen NR; Fang Y; Lu X; Sukhanova M; Chen Q; Chen YH
Hum Pathol; 2020 Nov; 105():20-30. PubMed ID: 32890601
[TBL] [Abstract][Full Text] [Related]
58. [Clinical Characteristics of Aggressive NK-Cell Leukemia].
Liao Y; He HS; Wei YF; Shen DP; Ji XY; Huang C; Huang J; Jin XK; Huang DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1026-1031. PubMed ID: 37551472
[TBL] [Abstract][Full Text] [Related]
59. Six cases of aggressive natural killer-cell leukemia in a Chinese population.
Zhang Q; Jing W; Ouyang J; Zeng H; George SK; Liu Z
Int J Clin Exp Pathol; 2014; 7(6):3423-31. PubMed ID: 25031771
[TBL] [Abstract][Full Text] [Related]
60. Three cases of aggressive natural killer cell leukemia with a lethal hemorrhagic complication.
Okuno Y; Tatetsu H; Nosaka K; Mitsuya H
J Clin Exp Hematop; 2012; 52(2):101-6. PubMed ID: 23037625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
